cagrilintide novo nordisk shares slide despite promising weight loss trial results Novo Nordisk launches trial of

Testosterone treatment of men with mild cognitive impairment and low testosterone levels

Therapeutic applications focus on insomnia and difficulty falling or staying asleep, insufficient deep sleep despite adequate sleep duration, sleep disruption from stress or irregular schedules, recovery optimization for athletes or high performers, circadian rhythm disorders from travel or shift work, sleep quality decline associated with aging, and comprehensive wellness protocols recognizing sleep as foundational to metabolic health, cognitive function, immune resilience, and longevity

SripadaRKKingAPGarfinkelSNWangXSripadaCSWelshRCet al

We are direct about the limits of the evidence